

315
24.- Deng M, Deng L, Xue Y. MAP Kinase-Mediated
and MLCK-Independent Phosphorylation of MLC20 in
Smooth Muscle Cells. From Molecules to Humans, Dr.
Haruo Sugi (Ed.), In Tech, 2012. doi: 10.5772/47732.
25.- Bos C, Richel D, Ritsema T, Peppelen-
bosch M, Versteeg H. Prostanoids and Prostanoid
Receptors in Signal Transduction. The International Jour-
nal of Biochemistry & Cell Biology 2004; 36: 1187-205.
26.- Daff S. NO synthase: Structures and mechanisms.
Nitric Oxide-Biology and Chemistry. 2010; 23: 1-11.
27.- Flavahan S, Flavahan NA. The atypical struc-
ture and function of newborn arterial endothelium is
mediated by Rho/Rho kinase signaling. Am J Physiol.
Heart and circulatory physiol 2014; 307: H628-H632.
28.- Gao Y, Cornfield DN, Stenmark KR, Thé-
baud B, Abman SH, Raj JU. Unique Aspects of
the Developing Lung Circulation: Structural Develop-
ment and Regulation of Vasomotor Tone 1. Pulmonary
Circulation 2016; 6: 407-25.
29.- Herrera EA, Reyes VR, Guissani DA, Ri-
quelme RA, Sanhueza EM, Ebensperger
G, et al. Carbon monoxide: a novel pulmonary artery
vasodilator in neonatal llamas of the Andean altiplano.
Cardiovasc Res. 2008; 77: 197-201.
30.- Ryter SW, Choi AMK. Targeting heme oxygena-
se-1 and carbon monoxide for therapeutic modulation of
inflammation. Translational Research. 2016; 167: 7-34.
31.- Derbyshire ER, Marletta MA. Biochemistry
of soluble guanylate cyclase. Handbook of experimental
pharmacology 2009; 191: 17-31.
32.- Jernigan NL, Walker BR, Resta TC. Reacti-
ve oxygen species mediate RhoA/Rho kinase-induced
Ca2+ sensitization in pulmonary vascular smooth
muscle following chronic hypoxia. Am J Physiol-Lung
cellular and molecular physiology. 2008; 1: 515-29.
33.- Vanhoutte PM, Shimokawa H, Feletou
M, Tang EHC. Endothelial dysfunction and vascular
disease - a 30th anniversary update. Acta Physiol. 2015;
219: 22-96.
34.- Batoule M, Raouf K. Molecular mechanisms
regulating the vascular prostacyclin pathways and their
adaptation during pregnancy and in the newborn. Phar-
macol Rev 2012; 64: 540-82.
35.- Stacy LD, Stokes P Jr. PGI2 as a regulator of
in ammatory diseases. Mediators of In ammation.
2012; 2012: 1-9.
Correspondencia a:
Germán Ebensperger Darrouy, PhD.
Profesor Asistente. Programa de Fisiopatología.
Instituto de Ciencias Biomédicas
Facultad de Medicina. Universidad de Chile.
Avda. Salvador 486, Providencia. Santiago de Chile.
Email:
gebensperger@med.uchile.clRev Chil Enferm Respir 2017; 33: 308-315
Mecanismos regulatorios del tono vascular pulmonar neonatal. Una perspectivamolecular